CME GROUP INC
For the period ended Mar 31, 2025. Filed Apr 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed Apr 30, 2025
CME$309.09+1.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets at March 31 and December 31,
CONSOLIDATED BALANCE SHEETS
(dollars in millions, except par value data; shares in thousands)
| March 31, 2025 | December 31, 2024 | |
|---|---|---|
| (unaudited) | ||
| Assets | ||
| Current Assets: | ||
| Cash and cash equivalents | $1,405.3 | $2,892.4 |
| Marketable securities | 113.9 | 113.2 |
| Accounts receivable, net of allowance of $8.7 and $9.0 | 770.2 | 573.1 |
| Other current assets (includes $6.3 and $6.3 in restricted cash) | 461.5 | 559.4 |
| Performance bonds and guaranty fund contributions | 120,694.5 | 98,895.4 |
| Total current assets | 123,445.4 | 103,033.5 |
| Property, net of accumulated depreciation and amortization of $955.5 and $1,024.3 | 371.2 | 386.2 |
| Intangible assets—trading products | 17,175.3 | 17,175.3 |
| Intangible assets—other, net | 2,773.2 | 2,821.6 |
| Goodwill | 10,499.5 | 10,486.9 |
| Other assets | 3,567.0 | 3,543.5 |
| Total Assets | $157,831.6 | $137,447.0 |
| Liabilities and Equity | ||
| Current Liabilities: | ||
| Accounts payable | $100.2 | $79.9 |
| Short-term debt | — | 749.8 |
| Other current liabilities | 625.5 | 2,588.8 |
| Performance bonds and guaranty fund contributions | 120,694.5 | 98,895.4 |
| Total current liabilities | 121,420.2 | 102,313.9 |
| Long-term debt | 3,419.4 | 2,678.2 |
| Deferred income tax liabilities, net | 5,240.1 | 5,246.8 |
| Other liabilities | 721.2 | 721.2 |
| Total Liabilities | 130,800.9 | 110,960.1 |
| Shareholders’ Equity: | ||
| Preferred stock, $0.01 par value, 10,000 shares authorized as of March 31, 2025 and December 31, 2024; 4,584 issued and outstanding as of March 31, 2025 and December 31, 2024 | — | — |
| Class A common stock, $0.01 par value, 1,000,000 shares authorized at March 31, 2025 and December 31, 2024; 359,646 and 359,602 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 3.6 | 3.6 |
| Class B common stock, $0.01 par value, 3 shares authorized, issued and outstanding as of March 31, 2025 and December 31, 2024 | — | — |
| Additional paid-in capital | 22,416.0 | 22,403.0 |
| Retained earnings | 4,685.9 | 4,185.8 |
| Accumulated other comprehensive income (loss) | (74.8) | (105.5) |
| Total CME Group Shareholders’ Equity | 27,030.7 | 26,486.9 |
| Total Liabilities and Equity | $157,831.6 | $137,447.0 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.